Etigilimab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Etigilimab is a human-derived monoclonal antibody. Etigilimab targets TIGIT. It started clinical research for the treatment of advanced solid tumors in the United States in 2017
Etigilimab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Etigilimab is a human-derived monoclonal antibody. Etigilimab targets TIGIT. It started clinical research for the treatment of advanced solid tumors in the United States in 2017
Read more ...